Bank of America’s Citius Pharmaceuticals CTXR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $599 | Buy |
377
+309
| +454% | +$491 | ﹤0.01% | 6591 |
|
|
2025
Q1 | $101 | Buy |
68
+13
| +24% | +$19 | ﹤0.01% | 6773 |
|
|
2024
Q4 | $220 | Sell |
55
-28,875
| -100% | -$116K | ﹤0.01% | 6640 |
|
|
2024
Q3 | $14.5K | Sell |
28,930
-130,492
| -82% | -$65.2K | ﹤0.01% | 5902 |
|
|
2024
Q2 | $92.9K | Buy |
159,422
+107,227
| +205% | +$62.5K | ﹤0.01% | 5449 |
|
|
2024
Q1 | $46.8K | Sell |
52,195
-128,421
| -71% | -$115K | ﹤0.01% | 5670 |
|
|
2023
Q4 | $137K | Buy |
180,616
+77,039
| +74% | +$58.2K | ﹤0.01% | 5338 |
|
|
2023
Q3 | $70.8K | Sell |
103,577
-20,731
| -17% | -$14.2K | ﹤0.01% | 5497 |
|
|
2023
Q2 | $149K | Buy |
124,308
+124,288
| +621,440% | +$149K | ﹤0.01% | 5188 |
|
|
2023
Q1 | $23 | Sell |
20
-135
| -87% | -$155 | ﹤0.01% | 6726 |
|
|
2022
Q4 | $122 | Buy |
155
+153
| +7,650% | +$120 | ﹤0.01% | 6807 |
|
|
2022
Q3 | $0 | Sell |
2
-52
| -96% | – | ﹤0.01% | 6967 |
|
|
2022
Q2 | $0 | Sell |
54
-17,962
| -100% | – | ﹤0.01% | 7181 |
|
|
2022
Q1 | $32K | Sell |
18,016
-87,621
| -83% | -$156K | ﹤0.01% | 6543 |
|
|
2021
Q4 | $162K | Buy |
105,637
+62,150
| +143% | +$95.3K | ﹤0.01% | 5801 |
|
|
2021
Q3 | $88K | Buy |
43,487
+6,923
| +19% | +$14K | ﹤0.01% | 5912 |
|
|
2021
Q2 | $127K | Buy |
+36,564
| New | +$127K | ﹤0.01% | 5599 |
|
|
2020
Q1 | – | Sell |
-1,631
| Closed | -$2K | – | 6207 |
|
|
2019
Q4 | $2K | Sell |
1,631
-3,938
| -71% | -$4.83K | ﹤0.01% | 6031 |
|
|
2019
Q3 | $5K | Buy |
5,569
+3,200
| +135% | +$2.87K | ﹤0.01% | 5995 |
|
|
2019
Q2 | $2K | Buy |
+2,369
| New | +$2K | ﹤0.01% | 6154 |
|
|
2019
Q1 | – | Sell |
-3
| Closed | – | – | 6321 |
|
|
2018
Q4 | $0 | Sell |
3
-3,434
| -100% | – | ﹤0.01% | 6337 |
|
|
2018
Q3 | $6K | Buy |
3,437
+3,435
| +171,750% | +$6K | ﹤0.01% | 6026 |
|
|
2018
Q2 | $0 | Buy |
+2
| New | – | ﹤0.01% | 6343 |
|